Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Philips claims US first for SMART CPR defibrillator :

This article was originally published in Clinica

Executive Summary

Philips Medical Systems has received US FDA 510(k) market clearance for what it claims is the first automated external defibrillator to advise responders whether to initially treat sudden cardiac arrest (SCA) with a defibrillation shock or with CPR followed by a shock - HeartStart FR2+ with SMART CPR. While defibrillation is recognised as the definitive treatment for ventricular fibrillation (VF) -the abnormal heart rhythm most often associated with SCA - studies have found that patients with a certain form of VF responded better to a defibrillation shock if they received CPR first, said the company.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT056904

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel